SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

Minimally Invasive Test for Chemotherapy-Induced Cardiotoxicity
Award last edited on: 6/12/2020

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$727,428
Award Phase
2
Solicitation Topic Code
97
Principal Investigator
Alberto Gandini

Company Information

Accel Diagnostics LLC

5750 Baum Boulevard
Pittsburgh, PA 15206
   (412) 355-0338
   info@acceldx.com
   www.acceldx.com
Location: Single
Congr. District: 18
County: Allegheny

Phase I

Contract Number: 75N92019C00002-0-9999-1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2019
Phase I Amount
$1
Direct to Phase II

Phase II

Contract Number: 75N92019C00002
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2019
Phase II Amount
$727,427
Cardiovascular toxicity CVTx is a serious short and long term complication of many anti cancer chemotherapeutic regimens Zamorano Lancellotti et al. In this Phase SBIR submission to continue the development and validation of Accel Diagnostics minimally invasive rapid cost effective and connected blood test the pScreen CVTx TM for the early detection and continuous of chemotheropy induced CVTx